Weekly signal · HPQ · Technology

HP Inc (HPQ) four-week recovery reaches 24.1% on weekly screen

The move has broadened beyond a one-week jump, but the support reads mixed once volume and relative strength are considered.

HP Inc
Latest30.05 USD
1W move10.2%
Volume0.8x
TrendActive
HP Inc computer hardware beside a market-data screen with weekly chart lines.

Market update

What happened

HP Inc (HPQ) ended the latest week at $30.05, with the weekly price path over 52 weeks showing the stock sustaining a sharp recent recovery in computer hardware.

The confirmation is constructive but not uniform. The weekly screen shows an active trend and Market Dynamics improvement, while lighter turnover and a Relative Strength reading of 16.2 keep the setup mixed.

Continue your research

Explore HPQ across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

HPQ coverage

Evidence context